Asia Pacific Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Large Molecule Bioanalytical Testing Services Market would witness market growth of 10.1% CAGR during the forecast period (2022-2028).

For the aim of studying pharmacokinetics and pharmacodynamics, bioanalytical testing enables a quantitative measurement of the active medicines and their metabolites in biological systems. It is carried out throughout the drug development value chain and is essential for lead optimization and advancing a therapeutic candidate. Pharmaceutical companies carry out in-house bioanalytical testing throughout the drug discovery and lead optimization stages, while outsourcing is used for longer-term toxicity and Phase II investigations.

It is generally accepted that a bioanalytical method must first be validated to show that it is appropriate for its intended purpose before being put into normal usage. For all development investigations, a GLP (Good Laboratory Practices) certified bioanalytical method is required (e.g., toxicology studies and human clinical trials). There is widespread agreement that at least the following validation parameters should be assessed for quantitative procedures, per the Food and Drug Administration (FDA) GLP guidance selectivity, calibration model, stability, accuracy (bias, precision), and limit of quantification. Limit of detection (LOD), recovery, repeatability, and ruggedness are additional variables that may need to be assessed (robustness).

The cancers of the lung (19.2%), liver (10.5%), and stomach (9.9%) were the most common causes of death due to cancer. The region faces a carried a substantial burden of cancer, both in terms of the incidence & mortality rates of cancer. Cancer deaths were on the decline, but the disease is still becoming more prevalent overall, particularly among females and people of younger ages. The increasing emphasis placed by governments throughout the world on preventing the spread of infectious diseases is making a substantial contribution to the expansion of the market for large molecule bioanalytical testing services.

The China market dominated the Asia Pacific Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $192.7 million by 2028. The Japan market is registering a CAGR of 9.4% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 10.7% during (2022 - 2028).

Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Large Molecule Bioanalytical Testing Services Market is Projected to reach USD 2.8 Billion by 2028, at a CAGR of 9.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-user

• SMEs
• Large Firms

By Test Type

• Bioavailability
• ADME
• PD
• Bioequivalence
• Others

By Type

• ADA
• Pharmacokinetics
• Others

By Phase

• Clinical
• Pre-clinical
  • With Antibody
  • Without Antibody (ELISA Based Assay)

By Therapeutic Areas

• Oncology
• Neurology
• Infectious Diseases
• Cardiology
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Laboratory Corporation Of America Holdings
• IQVIA Holdings, Inc.
• Syneos Health, Inc.
• SGS S.A.
• Intertek Group PLC
• Pace Analytical Services, LLC
• ICON Plc
• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by End-user
1.4.2 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by Test Type
1.4.3 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by Type
1.4.4 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by Phase
1.4.5 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by Therapeutic Areas
1.4.6 Asia Pacific Large Molecule Bioanalytical Testing Services Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Large Molecule Bioanalytical Testing Services Market

Chapter 4. Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user
4.1 Asia Pacific SMEs Market by Country
4.2 Asia Pacific Large Firms Market by Country

Chapter 5. Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type
5.1 Asia Pacific Bioavailability Market by Country
5.2 Asia Pacific ADME Market by Country
5.3 Asia Pacific PD Market by Country
5.4 Asia Pacific Bioequivalence Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type
6.1 Asia Pacific ADA Market by Country
6.2 Asia Pacific Pharmacokinetics Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase
7.1 Asia Pacific Clinical Market by Country
7.2 Asia Pacific Pre-clinical Market by Country
7.3 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
7.3.1 Asia Pacific With Antibody Market by Country
7.3.2 Asia Pacific Without Antibody (ELISA Based Assay) Market by Country

Chapter 8. Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
8.1 Asia Pacific Oncology Market by Country
8.2 Asia Pacific Neurology Market by Country
8.3 Asia Pacific Infectious Diseases Market by Country
8.4 Asia Pacific Cardiology Market by Country
8.5 Asia Pacific Others Market by Country

Chapter 9. Asia Pacific Large Molecule Bioanalytical Testing Services Market by Country
9.1 China Large Molecule Bioanalytical Testing Services Market
9.1.1 China Large Molecule Bioanalytical Testing Services Market by End-user
9.1.2 China Large Molecule Bioanalytical Testing Services Market by Test Type
9.1.3 China Large Molecule Bioanalytical Testing Services Market by Type
9.1.4 China Large Molecule Bioanalytical Testing Services Market by Phase
9.1.4.1 China Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.1.5 China Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.2 Japan Large Molecule Bioanalytical Testing Services Market
9.2.1 Japan Large Molecule Bioanalytical Testing Services Market by End-user
9.2.2 Japan Large Molecule Bioanalytical Testing Services Market by Test Type
9.2.3 Japan Large Molecule Bioanalytical Testing Services Market by Type
9.2.4 Japan Large Molecule Bioanalytical Testing Services Market by Phase
9.2.4.1 Japan Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.2.5 Japan Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.3 India Large Molecule Bioanalytical Testing Services Market
9.3.1 India Large Molecule Bioanalytical Testing Services Market by End-user
9.3.2 India Large Molecule Bioanalytical Testing Services Market by Test Type
9.3.3 India Large Molecule Bioanalytical Testing Services Market by Type
9.3.4 India Large Molecule Bioanalytical Testing Services Market by Phase
9.3.4.1 India Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.3.5 India Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.4 South Korea Large Molecule Bioanalytical Testing Services Market
9.4.1 South Korea Large Molecule Bioanalytical Testing Services Market by End-user
9.4.2 South Korea Large Molecule Bioanalytical Testing Services Market by Test Type
9.4.3 South Korea Large Molecule Bioanalytical Testing Services Market by Type
9.4.4 South Korea Large Molecule Bioanalytical Testing Services Market by Phase
9.4.4.1 South Korea Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.4.5 South Korea Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.5 Singapore Large Molecule Bioanalytical Testing Services Market
9.5.1 Singapore Large Molecule Bioanalytical Testing Services Market by End-user
9.5.2 Singapore Large Molecule Bioanalytical Testing Services Market by Test Type
9.5.3 Singapore Large Molecule Bioanalytical Testing Services Market by Type
9.5.4 Singapore Large Molecule Bioanalytical Testing Services Market by Phase
9.5.4.1 Singapore Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.5.5 Singapore Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.6 Malaysia Large Molecule Bioanalytical Testing Services Market
9.6.1 Malaysia Large Molecule Bioanalytical Testing Services Market by End-user
9.6.2 Malaysia Large Molecule Bioanalytical Testing Services Market by Test Type
9.6.3 Malaysia Large Molecule Bioanalytical Testing Services Market by Type
9.6.4 Malaysia Large Molecule Bioanalytical Testing Services Market by Phase
9.6.4.1 Malaysia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.6.5 Malaysia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.7 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market
9.7.1 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user
9.7.2 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type
9.7.3 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type
9.7.4 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase
9.7.4.1 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.7.5 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas

Chapter 10. Company Profiles
10.1 IQVIA Holdings, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Product Launches and Product Expansions:
10.1.4.2 Geographical Expansions:
10.2 SGS S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Geographical Expansions:
10.3 Intertek Group PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.4 ICON plc
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Charles River Laboratories International, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Acquisition and Mergers:
10.6 Thermo Fisher Scientific, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Syneos Health, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.8 Laboratory Corporation Of America Holdings
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Geographical Expansions:
10.9 Pace Analytical Services, LLC
10.9.1 Company Overview

TABLE 1 Asia Pacific Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 5 Asia Pacific SMEs Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific SMEs Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Large Firms Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Large Firms Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Bioavailability Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Bioavailability Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific ADME Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific ADME Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific PD Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific PD Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Bioequivalence Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Bioequivalence Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 23 Asia Pacific ADA Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific ADA Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Pharmacokinetics Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Pharmacokinetics Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Clinical Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Clinical Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Pre-clinical Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Pre-clinical Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 37 Asia Pacific With Antibody Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific With Antibody Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Without Antibody (ELISA Based Assay) Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Without Antibody (ELISA Based Assay) Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 43 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
TABLE 45 Asia Pacific Neurology Market by Country, 2018 - 2021, USD Million
TABLE 46 Asia Pacific Neurology Market by Country, 2022 - 2028, USD Million
TABLE 47 Asia Pacific Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 48 Asia Pacific Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 49 Asia Pacific Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 50 Asia Pacific Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 51 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 52 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 53 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Country, 2018 - 2021, USD Million
TABLE 54 Asia Pacific Large Molecule Bioanalytical Testing Services Market by Country, 2022 - 2028, USD Million
TABLE 55 China Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 56 China Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 57 China Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 58 China Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 59 China Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 60 China Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 61 China Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 62 China Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 63 China Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 64 China Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 65 China Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 66 China Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 67 China Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 68 China Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 69 Japan Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 70 Japan Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 71 Japan Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 72 Japan Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 73 Japan Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 74 Japan Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 75 Japan Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 76 Japan Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 77 Japan Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 78 Japan Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 79 Japan Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 80 Japan Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 81 Japan Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 82 Japan Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 83 India Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 84 India Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 85 India Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 86 India Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 87 India Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 88 India Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 89 India Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 90 India Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 91 India Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 92 India Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 93 India Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 94 India Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 95 India Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 96 India Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 97 South Korea Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 98 South Korea Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 99 South Korea Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 100 South Korea Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 101 South Korea Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 102 South Korea Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 103 South Korea Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 104 South Korea Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 105 South Korea Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 106 South Korea Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 107 South Korea Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 108 South Korea Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 109 South Korea Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 110 South Korea Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 111 Singapore Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 112 Singapore Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 113 Singapore Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 114 Singapore Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 115 Singapore Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 116 Singapore Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 117 Singapore Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 118 Singapore Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 119 Singapore Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 120 Singapore Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 121 Singapore Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 122 Singapore Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 123 Singapore Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 124 Singapore Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 125 Malaysia Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 126 Malaysia Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 127 Malaysia Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 128 Malaysia Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 129 Malaysia Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 130 Malaysia Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 131 Malaysia Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 132 Malaysia Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 133 Malaysia Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 134 Malaysia Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 135 Malaysia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 136 Malaysia Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 137 Malaysia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 138 Malaysia Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 139 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 140 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 141 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 142 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 143 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 144 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 145 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 146 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 147 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 148 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 149 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 150 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 151 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 152 Rest of Asia Pacific Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 153 Key information – IQVIA Holdings, Inc.
TABLE 154 Key Information – SGS S.A.
TABLE 155 Key Information – Intertek Group PLC
TABLE 156 Key Information – ICON PLC
TABLE 157 key information – Charles River Laboratories International, Inc.
TABLE 158 Key Information – Thermo Fisher Scientific, Inc.
TABLE 159 Key Information – Syneos Health, Inc.
TABLE 160 Key Information – Laboratory Corporation Of America Holdings
TABLE 161 Key Information – Pace Analytical Services, LLC

List of Figures
FIG 1 Methodology for the research